Lifestyle Medicine - Redefining Healthcare to Promote Wellbeing

---

LIVEDHPAMA

Saturday, February 17, 2024, 8:30 AM - 5:30 PM, Weill Cornell Medicine-Qatar, Live stream, Doha, Qatar

The symposium on lifestyle medicine will bring together experts to focus on current and progressive advances in lifestyle medicine education, medical practice, and research. The symposium will provide insights on how the overwhelming burden of chronic disease can be prevented, managed, and reversed by using evidence based intensive lifestyle-related therapeutic interventions. It provides an opportunity on how lifestyle medicine is redefining healthcare to promote wellbeing and empower patients and communities to engage in self-care. Overall, the symposium will foster an exchange of ideas and engage in interdisciplinary conversations to advance health and well-being of patients, communities, and populations

1. Discuss the role of lifestyle medicine in redefining healthcare
2. Describe how the realm of lifestyle medicine promotes wellbeing
3. Examine lifestyle medicine advances, challenges, and opportunities

ACCME Accreditation Statement  The Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians ACCME Credit Designation Statement The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. DHP Accreditation Statement Weill Cornell Medicine-Qatar is accredited as a provider of Continuing Medical Education (CME) and Continuing Professional Development (CPD) by the Department of Healthcare Professions - Accreditation Section (DHP-AS). DHP Credit Designation Statement This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 6.75 hours.

Disclosure of Relationships/Content Validity 

It is the policy of Weill Cornell Medicine-Qatar to adhere to Ministry of Public Health’s Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias.

Scientific Planning Committee

Joel Anison, Mark Santos, Raji Anand, Ravinder Mamtani, Samaah Shams Chalil, Sandhya Vijayakumar, Sohaila Cheema, Sunil Suresh Harikrishnan, Yaqeen Mahdi, Yasmeen Kalverts  

• Have no relevant financial relationship to disclose. 
• Will not be discussing unlabeled/unapproved use of drugs or products.

Course Directors

Ravinder Mamtani, Sohaila Cheema:

• Have no relevant financial relationship to disclose. 
• Will not be discussing unlabeled/unapproved use of drugs or products.

Course Faculty

Javaid Sheikh, Jenny Lee, Mechelle Palma, Mohamed Al-Thani, Moyosore Makinde, Padmaja Patel, Rabbanie Tariq Wani, Ravinder Mamtani, Samar ElFeky, Sathyanarayan Doraiswamy, Shagufta Feroz, Silvia Lagrotta, Sivaneswaran Poobalasingam, Sohaila Cheema, Stephan Herzog, Victor Saadia, Wayne Dysinger:

Have no relevant financial relationship to disclose. 
Will not be discussing unlabeled/unapproved use of drugs or products.

Agnese Lapsa-Lešinske:
Has disclosed the following relationships: Independent Contractor - International Board of Lifestyle Medicine and American College of Lifestyle Medicine
Will not be discussing unlabeled/unapproved use of drugs or products.

Amy Mechley:
Has disclosed the following relationships: Membership on Advisory Committees or Review Panels, Board Membership - Midmark.
Will not be discussing unlabeled/unapproved use of drugs or products.

Daniel Sliz:
Has disclosed the following relationships:
Speaker Bureaus: Sanofi, Egis, USP, Polpharma, Chiesi, Viatris – Relationship ended
Advisor: Sense Medical Center
Will not be discussing unlabeled/unapproved use of drugs or products.

Course Administrator

Sandhya Vijayakumar:
Has no relevant financial relationships to disclose.
Will not be discussing unlabeled/unapproved use of drugs or products. 

---

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.

---

Evaluation

An evaluation will be conducted online post activity. All participants are required to complete the evaluation to receive a certificate. The evaluation allows us to assess the degree to which the activity met its objectives. It will also guide the planning of future activities and inform decisions about improving the educational program.

 

Mitigation of Relevant Financial Relationships

Weill Cornell Medicine-Qatar adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.